Company Filing History:
Years Active: 2000-2001
Title: Dario Doller - Innovator in Pharmaceutical Chemistry
Introduction
Dario Doller is a notable inventor based in North Wales, PA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of thrombin receptor antagonists. With a total of 2 patents to his name, Doller continues to push the boundaries of innovation in his field.
Latest Patents
Doller's latest patents focus on thrombin receptor antagonists, specifically heterocyclic-substituted tricyclics. These compounds are described by the formula ##STR1## or a pharmaceutically acceptable salt thereof, where the single dotted line represents an optional double bond. His work in this area has the potential to impact therapeutic strategies significantly.
Career Highlights
Dario Doller is currently employed at Schering Corporation, where he applies his expertise in pharmaceutical research and development. His role at the company allows him to collaborate with other talented professionals in the industry, further enhancing his contributions to innovative drug development.
Collaborations
Throughout his career, Doller has worked alongside esteemed colleagues such as Samuel Chackalamannil and Theodros Asberom. These collaborations have fostered a creative environment that encourages the exchange of ideas and advancements in pharmaceutical science.
Conclusion
Dario Doller is a prominent figure in the realm of pharmaceutical innovation, with a focus on thrombin receptor antagonists. His work at Schering Corporation and his collaborations with other experts highlight his commitment to advancing medical science. Doller's contributions are paving the way for future developments in the field.